Dosage and administration
Adults & Children ages 7 - 12: 4 tablets. Children ages 2 - 6: 2 tablets. Dissolve under tongue 3 times a day. Use more frequently (every 15 minutes for up to 8 doses) with acute conditions.
Adults & Children ages 7 - 12: 4 tablets. Children ages 2 - 6: 2 tablets. Dissolve under tongue 3 times a day. Use more frequently (every 15 minutes for up to 8 doses) with acute conditions.
Adults & Children ages 7 - 12: 4 tablets. Children ages 2 - 6: 2 tablets. Dissolve under tongue 3 times a day. Use more frequently (every 15 minutes for up to 8 doses) with acute conditions.
Relief of symptoms of muscular cramps and pains (e.g.menstrual cramps) relieved by warmth,stomach cramps,headaches with darting pains.
Magnesia Phosphorica 30X HPUS
in a base of Acacia Gum, Lactose N.F.
“HPUS” indicates that the active ingredients are in the official Homeopathic Pharmacopœia of the United States.
Do not use if imprinted cap band is broken or missing.
If symptoms persist for more than 7 days or worsen, contact a licensed health care provider.
If you are pregnant or nursing, seek the advice of a licensed health care provider before using this product.
Keep all medications out of the reach of children.
(800) 624-9659
HOMEOPATHIC
NDC 54973-3108-1
Hyland's®
#8
Mag. Phos. 30X
Muscle Cramps
and Pains*
500 TABLETS
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54973-3108-1 | MAGNESIA PHOS | 500 in 1 BOTTLE, PLASTIC | TABLET | 500 | 4 | |
| 54973-3108-2 | MAGNESIA PHOS | 1000 in 1 BOTTLE, PLASTIC | TABLET | 1000 | 4 | |
| 54973-3108-3 | MAGNESIA PHOS | 250 in 1 BOTTLE, PLASTIC | TABLET | 250 | 4 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54973-3108 | MAGNESIA PHOS (MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE) TABLET [HYLAND'S INC.] | 4 | Current NDC, Legacy NDC, 3 package rows | 20221220_d6bf8ae0-5bf9-47b8-8a5b-0f59e05968c8.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE | ACTIVE INGREDIENT | HF539G9L3Q | 1 | |
| MAGNESIUM CATION | ACTIVE MOIETY | T6V3LHY838 | 1 | |
| ACACIA | INACTIVE INGREDIENT | 5C5403N26O | 1 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 54973-3108 | 54973-3108-1, 54973-3108-2, 54973-3108-3 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ACACIA | 5C5403N26O | IACT |
| LACTOSE | J2B2A4N98G | IACT |
| MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE | HF539G9L3Q | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ACACIA | ACACIA | 5C5403N26O | TABLET / ORAL | 70 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET / ORAL | 70 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET / ORAL | 70 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET / ORAL | 70 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MAGNESIA PHOS | MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE | Hyland's Inc. | d6bf8ae0-5bf9-47b8-8a5b-0f59e05968c8 | 2022-12-19 | Warnings | 54973-3108-1 54973-3108-3 54973-3108-2 54973-3108 54973310803 54973310801 54973310802 f0312ed9-d660-0c99-e053-2995a90a30fe d6bf8ae0-5bf9-47b8-8a5b-0f59e05968c8 |
Adverse event summaries are temporarily unavailable. Other product information remains available.